| Name | Title | Contact Details |
|---|
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.
American Clinical Solutions is a leading provider of urine drug confirmation services, offering accurate testing for both prescription and illicit narcotics using the most advanced equipment available. Medical facilities and other healthcare providers rely on American Clinical to help ensure patient safety and maximize the benefits of prescription medicine use. ACS employs a unique, proprietary testing method with enhanced detection ability and improved accuracy which means physicians and other health care providers can prescribe with confidence. In addition to detecting improper use of prescribed and illicit drugs, ACS testing method helps healthcare providers monitor the efficacy of prescription regimens and alter the dosing scheme in response to changes in patient health status, behavior or other variables, helping patients achieve better outcomes while providing an overall greater level of safety. ACS techniques and technology were developed to meet or exceed the latest testing standards. Input from our physician colleagues provides invaluable guidance to help us refine our approach to ensure we continue to provide the best, most accurate testing results and reporting services available.
Solaris-Newtech, is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Custom Spine Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Parsippany, NJ. To find more information about Custom Spine Inc, please visit www.customspine.com